麦德伟博士专访

IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL University of Toronto Medical Journal Pub Date : 2010-06-14 DOI:10.5015/utmj.v87i3.1265

R. Vanner

{"title":"麦德伟博士专访","authors":"R. Vanner","doi":"10.5015/utmj.v87i3.1265","DOIUrl":null,"url":null,"abstract":"Dr. Tak W. Mak is Director of the Campbell Family Institute for Breast Cancer Research, Director of the Advanced Medical Discovery Institute, and Senior Scientist in the Division of Stem Cell and Developmental Biology. In 1984 he gained international notoriety for cloning the T-cell receptor, and he remains one of Canadaâ€™s most highly-cited scientists. His laboratory continues to study the mechanisms of the immune response and tumorigenesis, often with the use of genetically engineered mouse strains.","PeriodicalId":41298,"journal":{"name":"University of Toronto Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2010-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Interview with Dr. Tak W. Mak\",\"authors\":\"R. Vanner\",\"doi\":\"10.5015/utmj.v87i3.1265\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dr. Tak W. Mak is Director of the Campbell Family Institute for Breast Cancer Research, Director of the Advanced Medical Discovery Institute, and Senior Scientist in the Division of Stem Cell and Developmental Biology. In 1984 he gained international notoriety for cloning the T-cell receptor, and he remains one of Canadaâ€™s most highly-cited scientists. His laboratory continues to study the mechanisms of the immune response and tumorigenesis, often with the use of genetically engineered mouse strains.\",\"PeriodicalId\":41298,\"journal\":{\"name\":\"University of Toronto Medical Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2010-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"University of Toronto Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5015/utmj.v87i3.1265\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"University of Toronto Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5015/utmj.v87i3.1265","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

Tak W. Mak博士是Campbell Family Institute for Breast Cancer Research的主任，Advanced Medical Discovery Institute的主任，以及干细胞和发育生物学部门的高级科学家。1984年，他因克隆t细胞受体而在国际上声名狼藉，他仍然是加拿大被引用次数最多的科学家之一。他的实验室继续研究免疫反应和肿瘤发生的机制，经常使用基因工程小鼠品系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

An Interview with Dr. Tak W. Mak

Dr. Tak W. Mak is Director of the Campbell Family Institute for Breast Cancer Research, Director of the Advanced Medical Discovery Institute, and Senior Scientist in the Division of Stem Cell and Developmental Biology. In 1984 he gained international notoriety for cloning the T-cell receptor, and he remains one of Canadaâ€™s most highly-cited scientists. His laboratory continues to study the mechanisms of the immune response and tumorigenesis, often with the use of genetically engineered mouse strains.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

University of Toronto Medical Journal MEDICINE, GENERAL & INTERNAL-

CiteScore

0.30

自引率

0.00%

发文量